Home69C • FRA
Follow
Cara Therapeutics Inc
Previous close
€0.63
Day range
€0.60 - €0.60
Year range
€0.44 - €4.04
Market cap
39.95M USD
Avg Volume
753.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 3.00M | -7.88% |
Operating expense | 7.72M | 2.12% |
Net income | -32.34M | -6.59% |
Net profit margin | -1.08K | -15.70% |
Earnings per share | -0.59 | -5.36% |
EBITDA | -32.52M | -4.09% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 100.76M | -30.70% |
Total assets | 125.84M | -30.94% |
Total liabilities | 68.76M | 193.12% |
Total equity | 57.08M | — |
Shares outstanding | 54.66M | — |
Price to book | 0.60 | — |
Return on assets | -67.60% | — |
Return on capital | -84.38% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -32.34M | -6.59% |
Cash from operations | -17.37M | 26.12% |
Cash from investing | -30.20M | -167.99% |
Cash from financing | 36.48M | 165,695.45% |
Net change in cash | -11.10M | -153.02% |
Free cash flow | -9.26M | 24.67% |
About
Founded
2004
Headquarters
Website
Employees
55